Evidence map›Paper›PMID 18505376›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2009

Bone disease in thalassemia: a frequent and still unresolved problem.

Maria G Vogiatzi, Eric A Macklin, Ellen B Fung, Angela M Cheung, Elliot Vichinsky, Nancy Olivieri, Melanie Kirby, Janet L Kwiatkowski, Melody Cunningham, Ingrid A Holm and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 5 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 5 syntheses or guidelines pooled it, 242 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Pooled it
  4. Guideline
  5. Pooled it
  6. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Maria G VogiatziDepartment of Pediatrics, Weill Medical College of Cornell, New York, New York, USA. mvogiatz@med.cornell.edu
Eric A Macklin
Ellen B Fung
Angela M Cheung
Elliot Vichinsky
Nancy Olivieri
Melanie Kirby
Janet L Kwiatkowski
Melody Cunningham
Ingrid A Holm
Joseph Lane
Robert Schneider
Martin Fleisher
Robert W Grady
Charles C Peterson
Patricia J Giardina
Thalassemia Clinical Research Network
Cornell University · USBoston Children's Hospital · USHospital for Special Surgery · USUniversity Health Network · CAChildren's Hospital of Philadelphia · USHospital for Sick Children · CAMemorial Sloan Kettering Cancer Center · USNational Heart Lung and Blood Institute · USNew England Research Institutes · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
WIRELESS CAPSULE ENDOSCOPY TO EVALUATE THE SMALL INTESTINE M01RR002172 · NCRR · CHILDREN'S HOSPITAL BOSTON · PI MANDELL, JAMES WILLIAM · 1985 to 2008
$16.0M
Thalassemia Network - RegistryU01HL065238 · NHLBI · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 2000 to 2009
$13.3M
Thalassemia Clinical Research NetworkU01HL065239 · NHLBI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI VICHINSKY, ELLIOTT P · 2000 to 2009
$2.7M
Thalassemia Clinical Research Network, CanadaU01HL065233 · NHLBI · UNIVERSITY HEALTH NETWORK · PI OLIVIERI, NANCY F · 2000 to 2009
$2.6M
Thalassemia Clinical Research NetworkU01HL065244 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GIARDINA, PATRICIA J · 2000 to 2009
$2.3M
THE MID-ATLANTIC THALASSEMIA CONSORTIUMU01HL065232 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI KWIATKOWSKI, JANET L · 2000 to 2009
$2.0M
THALASSEMIA CLINICAL RESEARCH NETWORKU01HL065260 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI NEUFELD, ELLIS J · 2000 to 2009
$2.0M
Patient-Oriented Research in Pediatric HematologyK24HL004184 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI NEUFELD, ELLIS J · 1999 to 2010
$1.3M
Study of bone disease in Thalassemia K08HL088231 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI VOGIATZI, MARIA G · 2006 to 2010
$630k
CIHR 44917NCRR NIH HHS M01 RR002172NCRR NIH HHS M01-RR02172NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1-RR024134NHLBI NIH HHS 5K24HL004184-08NHLBI NIH HHS K08 HL088231NHLBI NIH HHS K24 HL004184NHLBI NIH HHS U01 HL065232NHLBI NIH HHS U01 HL065233NHLBI NIH HHS U01 HL065238NHLBI NIH HHS U01 HL065239NHLBI NIH HHS U01 HL065244NHLBI NIH HHS U01 HL065260NHLBI NIH HHS U01-HL-65232NHLBI NIH HHS U01-HL-65233NHLBI NIH HHS U01-HL-65238NHLBI NIH HHS U01-HL-65239NHLBI NIH HHS U01-HL-65244NHLBI NIH HHS U01-HL-65260
6 · The paper itself

Abstract

Adults with beta thalassemia major frequently have low BMD, fractures, and bone pain. The purpose of this study was to determine the prevalence of low BMD, fractures, and bone pain in all thalassemia syndromes in childhood, adolescence, and adulthood, associations of BMD with fractures and bone pain, and etiology of bone disease in thalassemia. Patients of all thalassemia syndromes in the Thalassemia Clinical Research Network, > or =6 yr of age, with no preexisting medical condition affecting bone mass or requiring steroids, participated. We measured spine and femur BMD and whole body BMC by DXA and assessed vertebral abnormalities by morphometric X-ray absorptiometry (MXA). Medical history by interview and review of medical records, physical examinations, and blood and urine collections were performed. Three hundred sixty-one subjects, 49% male, with a mean age of 23.2 yr (range, 6.1-75 yr), were studied. Spine and femur BMD Z-scores < -2 occurred in 46% and 25% of participants, respectively. Greater age, lower weight, hypogonadism, and increased bone turnover were strong independent predictors of low bone mass regardless of thalassemia syndrome. Peak bone mass was suboptimal. Thirty-six percent of patients had a history of fractures, and 34% reported bone pain. BMD was negatively associated with fractures but not with bone pain. Nine percent of participants had uniformly decreased height of several vertebrae by MXA, which was associated with the use of iron chelator deferoxamine before 6 yr of age. In patients with thalassemia, low BMD and fractures occur frequently and independently of the particular syndrome. Peak bone mass is suboptimal. Low BMD is associated with hypogonadism, increased bone turnover, and an increased risk for fractures.

Indexed as

Absorptiometry, PhotonAdolescentAdultAge DistributionAgingBiomarkersBone and BonesBone DensityBone DiseasesBone RemodelingChildFemaleHumansJointsMaleOrgan SizeBiomarkers

Identifiers

PMID18505376
PMCPMC3276604
OpenAlexW2059652841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.